Abstract
Regenerative medicine (RM) is a promising new field of medicine that has mobilized several new tools to repair or replace lost or damaged cells or tissues by stimulating natural regenerative mechanisms nearby cell and tissue-based therapy approaches. However, mesenchymal stem cell (MSC) based therapy has been shown to be safe and effective to a certain degree in multiple clinical trial studies (CTSs) of several diseases, in most MSC CTSs the efficacy of treatment has been reported low. Therefore, researchers have focused on efficacy enhancing of MSC to improve migratory and homing, survival, stemness, differentiation and other therapeutic applicable properties by using different approaches. Gene therapy is one of the experimental technique tools that uses genes to change cells for therapeutic and investigation purposes. In this study has been focused on genetically modified MSCs for use in RM with an emphasis on CTSs. We highlight the basic concept of genetic modifications and also discuss recent clinical studies aspects. Recently reviewed studies show that MSC therapy with assistant gene therapy can be used in cancer therapy, heart diseases, Fanconi anemia and several other diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- MSCs:
-
Mesenchymal stem cells
- GEMSC:
-
Gene engineering of mesenchymal stem cells
- ISCT:
-
International Society for Cellular Therapy
- CTSs:
-
Clinical trial studies
- RM:
-
Regenerative Medicine
References
Alemany R (2007) Cancer selective adenoviruses. Mol Asp Med 28:42–58. https://doi.org/10.1016/j.mam.2006.12.002
Alonso MM, Cascallo M, Gomez-Manzano C, Jiang H, Bekele BN, Perez-Gimenez A, Lang FF, Piao Y, Alemany R, Fueyo J (2007) ICOVIR-5 shows E2F1 addiction and potent Antiglioma effect in vivo. Cancer Res 67:8255–8263. https://doi.org/10.1158/0008-5472.CAN-06-4675
Altanerova V, Cihova M, Babic M, Rychly B, Ondicova K, Mravec B, Altaner C (2012) Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma. Int J Cancer 130:2455–2463. https://doi.org/10.1002/ijc.26278
Amano S, Li S, Gu C, Gao Y, Koizumi S, Yamamoto S, Terakawa S, Namba H (2009) Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. Int J Oncol 35:1265–1270
Baglio SR, Rooijers K, Koppers-Lalic D, Verweij FJ, Pérez Lanzón M, Zini N, Naaijkens B, Perut F, Niessen HWM, Baldini N, Pegtel DM (2015) Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther 6:127. https://doi.org/10.1186/s13287-015-0116-z
Bian L, Guo Z-K, Wang H-X, Wang J-S, Wang H, Li Q-F, Yang Y-F, Xiao F-J, Wu C-T, Wang L-S (2009) In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. In Vivo 23:21–27
Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076–1084. https://doi.org/10.1002/jcb.20886
Cascallo M, Alonso MM, Rojas JJ, Perez-Gimenez A, Fueyo J, Alemany R (2007) Systemic toxicity–efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway. Mol Ther 15:1607–1615. https://doi.org/10.1038/sj.mt.6300239
Cernat RI, Mihaescu T, Vornicu M, Vione D, Olariu RI, Arsene C (2011) Serum trace metal and ceruloplasmin variability in individuals treated for pulmonary tuberculosis. Int J Tuberc Lung Dis 15:1239–1245. https://doi.org/10.5588/ijtld.10.0445
Chakraborty S, Chopra P, Hak A, Dastidar SG, Ray A (2009) Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis. Expert Opin Investig Drugs 22:499–515. https://doi.org/10.1517/13543784.2013.778972
Chang W, Lee CY, Park J-H, Park M-S, Maeng L-S, Yoon CS, Lee MY, Hwang K-C, Chung Y-A (2013) Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1. J Vet Sci 14:69–76. https://doi.org/10.4142/JVS.2013.14.1.69
Chen J-J, Zhou S-H (2011) Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J 18:675–681
Coutu DL, Cuerquis J, El Ayoubi R, Forner K-A, Roy R, François M, Griffith M, Lillicrap D, Yousefi A-M, Blostein MD, Galipeau J (2011a) Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B. Biomaterials 32:295–305. https://doi.org/10.1016/j.biomaterials.2010.08.094
Coutu DL, Francois M, Galipeau J (2011b) Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood 117:6801–6812. https://doi.org/10.1182/blood-2010-12-321539
Cui L, Zhou X, Li J, Wang L, Wang J, Li Q, Chu J, Zheng L, Wu Q, Han Z, Shi Y, Han Y, Fan D (2012) Dynamic microRNA profiles of hepatic differentiated human umbilical cord lining-derived mesenchymal stem cells. PLoS One 7:e44737. https://doi.org/10.1371/journal.pone.0044737
Cyranoski D (2013) Stem cells reprogrammed using chemicals alone. Nature. https://doi.org/10.1038/nature.2013.13416
da Silva Meirelles L, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287–2299. https://doi.org/10.1634/stemcells.2007-1122
de Mayo T, Conget P, Becerra-Bayona S, Sossa CL, Galvis V, Arango-Rodríguez ML (2017) The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice. PLoS One 12:e0177533. https://doi.org/10.1371/journal.pone.0177533
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FF, Krause DDS, Deans RJR, Keating A, Prockop DDJ, Horwitz EME (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317. https://doi.org/10.1080/14653240600855905
Duan H-F, Wu C-T, Wu D-L, Lu Y, Liu H-J, Ha X-Q, Zhang Q-W, Wang H, Jia X-X, Wang L-S (2003) Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 8:467–474
Eskildsen T, Taipaleenmäki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S, Kassem M (2011) MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A 108:6139–6144. https://doi.org/10.1073/pnas.1016758108
Figueroa J, Phillips LM, Shahar T, Hossain A, Gumin J, Kim H, Bean AJ, Calin GA, Fueyo J, Walters ET, Kalluri R, Verhaak RG, Lang FF (2017) Exosomes from glioma-associated mesenchymal stem cells increase the Tumorigenicity of glioma stem-like cells via transfer of miR-1587. Cancer Res 77:5808–5819. https://doi.org/10.1158/0008-5472.CAN-16-2524
Firestein GS, Kelley WN (2017) Kelley’s textbook of rheumatology. Saunders/Elsevier, Philadelphia
Fischer S, Marquart KF, Pieper LA, Fieder J, Gamer M, Gorr I, Schulz P, Bradl H (2017) miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development. Biotechnol Bioeng 114:1495–1510. https://doi.org/10.1002/bit.26280
Gao F, He T, Wang H, Yu S, Yi D, Liu W, Cai Z (2007) A promising strategy for the treatment of ischemic heart disease: mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol 23:891–898
García-Castro J, Alemany R, Cascalló M, Martínez-Quintanilla J, del Mar Arriero M, Lassaletta Á, Madero L, Ramírez M (2010) Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Ther 17:476–483. https://doi.org/10.1038/cgt.2010.4
Gazdhar A, Susuri N, Hostettler K, Gugger M, Knudsen L, Roth M, Ochs M, Geiser T (2013) HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic. PLoS One 8:e65453. https://doi.org/10.1371/journal.pone.0065453
Glenn JD, Whartenby KA (2014) Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World J Stem Cells 6:526–539. https://doi.org/10.4252/wjsc.v6.i5.526
Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661–669. https://doi.org/10.1096/fj.05-5211com
Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC (2016) Paracrine mechanisms of mesenchymal stem cells in tissue repair. Humana Press, New York, pp 123–146
Golchin A, Asadpour R, Roshangar L, Jafari-Jozani R (2016) The effect of ammonium chloride concentration in in vitro maturation culture on ovine embryo development. J Reprod Infertil 17:144–150
Golchin A, Hosseinzadeh S, Roshangar L (2017) The role of nanomaterials in cell delivery systems. Med Mol Morphol 51:1–12. https://doi.org/10.1007/s00795-017-0173-8
Golchin A, Hosseinzadeh S, Ardeshirylajimi A (2018) The exosomes released from different cell types and their effects in wound healing. J Cell Biochem 119:5043–5052. https://doi.org/10.1002/jcb.26706
Gong M, Yu B, Wang J, Wang Y, Liu M, Paul C, Millard RW, Xiao D-S, Ashraf M, Xu M (2017) Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget 8:45200–45212. https://doi.org/10.18632/oncotarget.16778
Haider HK, Jiang S, Idris NM, Ashraf M (2008) IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1/CXCR4 signaling to promote myocardial repair. Circ Res 103:1300–1308. https://doi.org/10.1161/CIRCRESAHA.108.186742
Han J, Zhao J, Xu J, Wen Y (2014) Mesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice. Exp Ther Med 8:1330–1334. https://doi.org/10.3892/etm.2014.1918
Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12. https://doi.org/10.1186/1478-811X-9-12
Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ (2010) Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 21:1513–1526. https://doi.org/10.1089/hum.2010.165
Hong SJ, Jia S-X, Xie P, Xu W, Leung KP, Mustoe TA, Galiano RD (2013) Topically delivered adipose derived stem cells show an activated-fibroblast phenotype and enhance granulation tissue formation in skin wounds. PLoS One 8:e55640. https://doi.org/10.1371/journal.pone.0055640
Hori M, Juniantito V, Izawa T, Ichikawa C, Tanaka M, Tanaka K, Takenaka S, Kuwamura M, Yamate J (2013) Distribution of cells labelled by a novel somatic stem cell-recognizing antibody (A3) in pulmonary genesis and bleomycin induced pulmonary fibrosis in rats. J Comp Pathol 148:385–395. https://doi.org/10.1016/j.jcpa.2012.09.003
Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651–654. https://doi.org/10.1126/science.1239278
Hu R, Ling W, Xu W, Han D (2014) Fibroblast-like cells differentiated from adipose-derived mesenchymal stem cells for vocal fold wound healing. PLoS One 9:e92676. https://doi.org/10.1371/journal.pone.0092676
Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, Dzau VJ (2010) Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 106:1753–1762. https://doi.org/10.1161/CIRCRESAHA.109.196030
Huang F, Zhu X, Hu X-Q, Fang Z-F, Tang L, Lu X-L, Zhou S-H (2013) Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med 31:484–492. https://doi.org/10.3892/ijmm.2012.1200
Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557–563. https://doi.org/10.1038/nature06188
Kim JY, Shin KK, Lee AL, Kim YS, Park HJ, Park YK, Bae YC, Jung JS (2014) MicroRNA-302 induces proliferation and inhibits oxidant-induced cell death in human adipose tissue-derived mesenchymal stem cells. Cell Death Dis 5:e1385. https://doi.org/10.1038/cddis.2014.344
Kosaraju R, Rennert RC, Maan ZN, Duscher D, Barrera J, Whittam AJ, Januszyk M, Rajadas J, Rodrigues M, Gurtner GC (2016) Adipose-derived stem cell-seeded hydrogels increase endogenous progenitor cell recruitment and neovascularization in wounds. Tissue Eng Part A 22:295–305. https://doi.org/10.1089/ten.tea.2015.0277
Lai RC, Chen TS, Lim SK (2011) Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6:481–492. https://doi.org/10.2217/rme.11.35
Le Blanc K, Pittenger MF (2005) Mesenchymal stem cells: progress toward promise. Cytotherapy 7:36–45. https://doi.org/10.1080/14653240510018118
Lee J, Elkahloun AG, Messina SA, Ferrari N, Xi D, Smith CL, Cooper R, Albert PS, Fine HA, Dembinski J, Andreeff M, Lang FF (2003) Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector. Cancer Res 63:8877–8889. https://doi.org/10.1158/0008-5472.can-04-1874
Leung CC, Yu ITS, Chen W (2012) Silicosis. Lancet 379:2008–2018. https://doi.org/10.1016/S0140-6736(12)60235-9
Li W, Ma N, Ong L-L, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lützow K, Lendlein A, Stamm C, Li R-K, Steinhoff G (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25:2118–2127. https://doi.org/10.1634/stemcells.2006-0771
Li G-C, Ye Q-H, Xue Y-H, Sun H-J, Zhou H-J, Ren N, Jia H-L, Shi J, Wu J-C, Dai C, Dong Q-Z, Qin L-X (2010) Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci 101:2546–2553. https://doi.org/10.1111/j.1349-7006.2010.01738.x
Li C, Wei G, Gu Q, Wang Q, Tao S, Xu L (2015a) Proliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection. Med Sci Monit 21:845–854. https://doi.org/10.12659/MSM.893144
Li M, Zhao Y, Hao H, Dai H, Han Q, Tong C, Liu J, Han W, Fu X (2015b) Mesenchymal stem cell-conditioned medium improves the proliferation and migration of keratinocytes in a diabetes-like microenvironment. Int J Low Extrem Wounds 14:73–86. https://doi.org/10.1177/1534734615569053
Liang X, Zhang L, Wang S, Han Q, Zhao RC (2016) Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci 129:2182–2189. https://doi.org/10.1242/jcs.170373
Lim S, Kim Y, Ahn Y, Jeong M, Hong M, Joo S, Nam K, Cho J, Kang P, Park J (2006) The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 70:530–542. https://doi.org/10.1016/j.cardiores.2006.02.016
Liu N, Olson EN (2010) MicroRNA regulatory networks in cardiovascular development. Dev Cell 18:510–525. https://doi.org/10.1016/j.devcel.2010.03.010
Liu Y, Carson-Walter E, Walter KA (2014) Chemokine receptor CXCR7 is a functional receptor for CXCL12 in brain endothelial cells. PLoS One 9:e103938. https://doi.org/10.1371/journal.pone.0103938
Liu WW, Wang HX, Yu W, Bi XY, Chen JY, Chen LZ, Ding L, Han DM, Guo ZK, Lei YX (2015) Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up. Genet Mol Res 14:10672–10681. https://doi.org/10.4238/2015.September.9.7
Lv F-J, Tuan RS, Cheung KMC, Leung VYL (2014) Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 32:1408–1419. https://doi.org/10.1002/stem.1681
Lv B, Li F, Fang J, Xu L, Sun C, Han J, Hua T, Zhang Z, Feng Z, Jiang X (2017) Hypoxia inducible factor 1α promotes survival of mesenchymal stem cells under hypoxia. Am J Transl Res 9:1521–1529
Ma H, Shi X, Yuan X, Ding Y (2016) IL-1β siRNA adenovirus benefits liver regeneration by improving mesenchymal stem cells survival after acute liver failure. Ann Hepatol 15:260–270. https://doi.org/10.5604/16652681.1193723
Ma P, Pan Y, Li W, Sun C, Liu J, Xu T, Shu Y (2017) Extracellular vesicles-mediated noncoding RNAs transfer in cancer. J Hematol Oncol 10:57. https://doi.org/10.1186/s13045-017-0426-y
Maijenburg MW, Gilissen C, Melief SM, Kleijer M, Weijer K, ten Brinke A, Roelofs H, Van Tiel CM, Veltman JA, de Vries CJM, van der Schoot CE, Voermans C (2012) Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. Stem Cells Dev 21:228–238. https://doi.org/10.1089/scd.2011.0076
Manis JP (2007) Knock out, knock in, knock down — genetically manipulated mice and the Nobel prize. N Engl J Med 357:2426–2429. https://doi.org/10.1056/NEJMp0707712
Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106–2120. https://doi.org/10.1016/S0140-6736(07)60983-0
Mathiyalagan P, Sahoo S (2017) Exosomes-based gene therapy for MicroRNA delivery. Methods Mol Biol 1521:139–152. https://doi.org/10.1007/978-1-4939-6588-5_9
Meng F, Rui Y, Xu L, Wan C, Jiang X, Li G (2014) Aqp1 enhances migration of bone marrow mesenchymal stem cells through regulation of FAK and β-catenin. Stem Cells Dev 23:66–75. https://doi.org/10.1089/scd.2013.0185
Merten O-W, Al-Rubeai M (2011) Viral vectors for gene therapy: methods and protocols. Humana Press, Totowa
Moriyama H, Moriyama M, Isshi H, Ishihara S, Okura H, Ichinose A, Ozawa T, Matsuyama A, Hayakawa T (2014) Role of notch signaling in the maintenance of human mesenchymal stem cells under hypoxic conditions. Stem Cells Dev 23:2211–2224. https://doi.org/10.1089/scd.2013.0642
Muñoz Ruiz M, Regueiro JR (2012) New tools in regenerative medicine: gene therapy. Adv Exp Med Biol 741:254–275
Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P (2013) Delivery of functional anti-miR-9 by mesenchymal stem cell–derived exosomes to glioblastoma Multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids 2:e126. https://doi.org/10.1038/MTNA.2013.60
Nakamura Y, Ishikawa H, Kawai K, Tabata Y, Suzuki S (2013) Enhanced wound healing by topical administration of mesenchymal stem cells transfected with stromal cell-derived factor-1. Biomaterials 34:9393–9400. https://doi.org/10.1016/j.biomaterials.2013.08.053
Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J (2011) Locally administered adipose-derived stem cells accelerate wound healing through differentiation and Vasculogenesis. Cell Transplant 20:205–216. https://doi.org/10.3727/096368910X520065
Niess H, Bao Q, Conrad C, Zischek C, Notohamiprodjo M, Schwab F, Schwarz B, Huss R, Jauch K-W, Nelson PJ, Bruns CJ (2011) Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg 254:767–775. https://doi.org/10.1097/SLA.0b013e3182368c4f
Niess H, von Einem JC, Thomas MN, Michl M, Angele MK, Huss R, Günther C, Nelson PJ, Bruns CJ, Heinemann V (2015) Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial. BMC Cancer 15:237. https://doi.org/10.1186/s12885-015-1241-x
Nombela-Arrieta C, Ritz J, Silberstein LE (2011) The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 12:126–131. https://doi.org/10.1038/nrm3049
Nowakowski A, Walczak P, Lukomska B, Janowski M (2016) Genetic engineering of mesenchymal stem cells to induce their migration and survival. Stem Cells Int 2016:4956063. https://doi.org/10.1155/2016/4956063
Nuschke A (2014) Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogenesis 10:29–37. https://doi.org/10.4161/org.27405
O’Brien KP, Khan S, Gilligan KE, Zafar H, Lalor P, Glynn C, O’Flatharta C, Ingoldsby H, Dockery P, De Bhulbh A, Schweber JR, St John K, Leahy M, Murphy JM, Gallagher WM, O’Brien T, Kerin MJ, Dwyer RM (2018) Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379. Oncogene 1:2137–2149. https://doi.org/10.1038/s41388-017-0116-9
Otani K, Yamahara K, Ohnishi S, Obata H, Kitamura S, Nagaya N (2009) Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles. J Control Release 133:146–153. https://doi.org/10.1016/j.jconrel.2008.09.088
Park JS, Suryaprakash S, Lao Y-H, Leong KW (2015) Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods 84:3–16. https://doi.org/10.1016/j.ymeth.2015.03.002
Pirmoradi S, Fathi E, Farahzadi R, Pilehvar-Soltanahmadi Y, Zarghami N (2017) Curcumin affects adipose tissue-derived mesenchymal stem cell aging through TERT gene expression. Drug Res (Stuttg) 68:213–221. https://doi.org/10.1055/s-0043-119635
Post DE, Khuri FR, Simons JW, van Meir EG (2003) Replicative oncolytic adenoviruses in multimodal Cancer regimens. Hum Gene Ther 14:933–946. https://doi.org/10.1089/104303403766682205
Rhee K-J, Lee J, Eom Y (2015) Mesenchymal stem cell-mediated effects of tumor support or suppression. Int J Mol Sci 16:30015–30033. https://doi.org/10.3390/ijms161226215
Sage EK, Kolluri KK, McNulty K, Lourenco SDS, Kalber TL, Ordidge KL, Davies D, Gary Lee YC, Giangreco A, Janes SM (2014) Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma. Thorax 69:638–647. https://doi.org/10.1136/thoraxjnl-2013-204110
Sage EK, Thakrar RM, Janes SM (2016) Genetically modified mesenchymal stromal cells in cancer therapy. Cytotherapy 18:1435–1445. https://doi.org/10.1016/j.jcyt.2016.09.003
Sandhaanam SD, Pathalam G, Dorairaj S, Savariar V, Nadu T (2013) Mesenchymal stem cells (MSC): identification, proliferation and differentiation – a review article. PeerJ Prepr 148:1–13. https://doi.org/10.7287/peerj.preprints.148v1
Sauni R, Oksa P, Lehtimäki L, Toivio P, Palmroos P, Nieminen R, Moilanen E, Uitti J (2012) Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers. Occup Environ Med 69:256–260. https://doi.org/10.1136/oemed-2011-100347
Senís E, Mockenhaupt S, Rupp D, Bauer T, Paramasivam N, Knapp B, Gronych J, Grosse S, Windisch MP, Schmidt F, Theis FJ, Eils R, Lichter P, Schlesner M, Bartenschlager R, Grimm D (2017) TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus. Nucleic Acids Res 45:e3–e3. https://doi.org/10.1093/nar/gkw805
Shaer A, Azarpira N, Vahdati A, Karimi M, Shariati M (2014) miR-375 induces human decidua basalis-derived stromal cells to become insulin-producing cells. Cell Mol Biol Lett 19:483–499. https://doi.org/10.2478/s11658-014-0207-3
Soheilifar MH, Taheri RA, Emameh RZ, Moshtaghian A, Kooshki H, Motie MR (2018) Molecular landscape in alveolar soft part sarcoma: implications for molecular targeted therapy. Biomed Pharmacother 103:889–896. https://doi.org/10.1016/j.biopha.2018.04.117
Squillaro T, Peluso G, Galderisi U (2016) Clinical trials with mesenchymal stem cells: an update. Cell Transplant 25:829–848. https://doi.org/10.3727/096368915X689622
Stintzing S, Modest DP, Rossius L, Lerch MM, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran S-E, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Held S, Giessen-Jung C, Moehler M, Jagenburg A, Kirchner T, Jung A, Heinemann V, FIRE-3 investigators (2016) FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. Lancet Oncol 17:1426–1434. https://doi.org/10.1016/S1470-2045(16)30269-8
Sun Z, Li T, Wen H, Wang H, Ji W, Ma Y (2015) Immunological effect induced by mesenchymal stem cells in a rat liver transplantation model. Exp Ther Med 10:401–406. https://doi.org/10.3892/etm.2015.2551
Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S (2013) Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton’s jelly and their differentiation potential to neural-like cells. J Med Assoc Thail 96:1208–1217
Tsubokawa T, Yagi K, Nakanishi C, Zuka M, Nohara A, Ino H, Fujino N, Konno T, Kawashiri M, Ishibashi-Ueda H, Nagaya N, Yamagishi M (2010) Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol 298:H1320–H1329. https://doi.org/10.1152/ajpheart.01330.2008
von Einem JC, Peter S, Günther C, Volk H-D, Grütz G, Salat C, Stoetzer O, Nelson PJ, Michl M, Modest DP, Holch JW, Angele M, Bruns C, Niess H, Heinemann V (2017) Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial. Oncotarget 8:80156–80166. https://doi.org/10.18632/oncotarget.20964
Walesky C, Apte U (2015) Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and Cancer. Gene Expr 16:101–108. https://doi.org/10.3727/105221615X14181438356292
Wang M, Tan J, Wang Y, Meldrum KK, Dinarello CA, Meldrum DR (2009) IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction. Proc Natl Acad Sci 106:17499–17504. https://doi.org/10.1073/pnas.0908924106
Won Y-W, Patel AN, Bull DA (2014) Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient. Biomaterials 35:5627–5635. https://doi.org/10.1016/j.biomaterials.2014.03.070
Wu N, Zhang Y-L, Wang H-T, Li D-W, Dai H-J, Zhang Q-Q, Zhang J, Ma Y, Xia Q, Bian J-M, Hang H-L (2016) Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation. Cancer Biol Ther 17:558–565. https://doi.org/10.1080/15384047.2016.1177675
Xie C, Xie D-Y, Lin B-L, Zhang G-L, Wang P-P, Peng L, Gao Z-L (2013) Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway. Br J Cancer 109:1198–1205. https://doi.org/10.1038/bjc.2013.422
Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, Shang X, Zhang ZG, Chopp M (2012) Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30:1556–1564. https://doi.org/10.1002/stem.1129
Xu G, Jiang X-D, Xu Y, Zhang J, Huang F-H, Chen Z-Z, Zhou D-X, Shang J-H, Zou Y-X, Cai Y-Q, Kou S-B, Chen Y-Z, Xu R-X, Zeng Y-J (2009) Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Cell Biol Int 33:466–474. https://doi.org/10.1016/j.cellbi.2008.07.023
Xu J, Huang Z, Lin L, Fu M, Gao Y, Shen Y, Zou Y, Sun A, Qian J, Ge J (2014) miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-met pathway activation. Sci China Life Sci 57:989–997. https://doi.org/10.1007/s11427-014-4725-z
Xu T-X, Zhao S-Z, Dong M, Yu X-R (2016) Hypoxia responsive miR-210 promotes cell survival and autophagy of endometriotic cells in hypoxia. Eur Rev Med Pharmacol Sci 20:399–406
Yan J, Zhang C, Zhao Y, Cao C, Wu K, Zhao L, Zhang Y (2014) Non-viral oligonucleotide antimiR-138 delivery to mesenchymal stem cell sheets and the effect on osteogenesis. Biomaterials 35:7734–7749. https://doi.org/10.1016/J.BIOMATERIALS.2014.05.089
Yeh T-S, Dean Fang Y-H, Lu C-H, Chiu S-C, Yeh C-L, Yen T-C, Parfyonova Y, Hu Y-C (2014) Baculovirus-transduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction. Biomaterials 35:174–184. https://doi.org/10.1016/j.biomaterials.2013.09.080
Youssef A, Aboalola D, Han VKM (2017) The roles of insulin-like growth factors in mesenchymal stem cell niche. Stem Cells Int 2017:9453108–9453112. https://doi.org/10.1155/2017/9453108
Yuan Z, Zhang J, Huang Y, Zhang Y, Liu W, Wang G, Zhang Q, Wang G, Yang Y, Li H, Chen G (2017) NRF2 overexpression in mesenchymal stem cells induces stem-cell marker expression and enhances osteoblastic differentiation. Biochem Biophys Res Commun 491:228–235. https://doi.org/10.1016/j.bbrc.2017.07.083
Zhang Q-Z, Su W-R, Shi S-H, Wilder-Smith P, Xiang AP, Wong A, Nguyen AL, Kwon CW, Le AD (2010) Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing. Stem Cells 28:1856–1868. https://doi.org/10.1002/stem.503
Zhang J, Hou L, Wu X, Zhao D, Wang Z, Hu H, Fu Y, He J (2016) Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo. Mol Cell Biochem 416:193–203. https://doi.org/10.1007/s11010-016-2707-0
Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Scholer HR, Duan LDS, Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Schöler HR, Duan L, Ding S (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381–384. https://doi.org/10.1016/j.stem.2009.04.005
Zhu Y, Feng X, Abbott J, Fang X, Hao Q, Monsel A, Qu J, Matthay MA, Lee JW (2014) Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 32:116–125. https://doi.org/10.1002/stem.1504
Zomer HD, Vidane AS, Gonçalves NN, Ambrósio CE (2015) Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives. Stem Cells Cloning Adv Appl 8:125–134. https://doi.org/10.2147/SCCAA.S88036
Acknowledgments
This study was supported by Baqiyatallah University of Medical Sciences (Project No. 96-12-002137).
Conflict of Interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Golchin, A., Rekabgardan, M., Taheri, R.A., Nourani, M.R. (2018). Promotion of Cell-Based Therapy: Special Focus on the Cooperation of Mesenchymal Stem Cell Therapy and Gene Therapy for Clinical Trial Studies. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 4. Advances in Experimental Medicine and Biology(), vol 1119. Springer, Cham. https://doi.org/10.1007/5584_2018_256
Download citation
DOI: https://doi.org/10.1007/5584_2018_256
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10485-6
Online ISBN: 978-3-030-10486-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)